🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

392 results for “CIS” Clear

  1. cisplatin oxaliplatin tegafur

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 1 small molecule active

    1 trial

  2. pCAR-19B cells

    Chongqing Precision Biotech Co., Ltd

    Acute Lymphoblastic Leukemia, in Relapse

    phase 1 mab active

    1 trial

  3. ​​A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants​

    Chongqing Precision Biotech Co., Ltd

    Epilepsy

    phase 1 other active

    1 trial

  4. Aerosolized 13 cis retinoic acid plus Vitamin D

    The First People's Hospital of Lianyungang

    Post COVID-19 Anosmia (Loss of Smell)

    approved small molecule active

    1 trial

  5. CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved small molecule active

    1 trial

  6. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved small molecule active

    1 trial

  7. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial

  8. Epoetin Alfa

    United Therapeutics Europe Ltd

    Exercise-Induced Anemia

    approved small molecule completed

    1 trial

  9. GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial

  10. Irinotecan liposomes combined with cisplatin/carboplatin

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    approved small molecule active

    1 trial

  11. Ocrevus 300 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications]

    approved small molecule active

    1 trial

  12. Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  13. Provase

    Chongqing Precision Biotech Co., Ltd

    Pruritus

    approved other completed

    1 trial

  14. Salkera Emollient Foam

    Chongqing Precision Biotech Co., Ltd

    Keratosis Pilaris

    approved small molecule terminated

    1 trial

  15. Tislelizumab + cisplatin + paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  16. Biobanking with genetic analysis

    Chongqing Precision Biotech Co., Ltd

    Chronic Inflammatory Disease

    gene therapy active

    1 trial

  17. CMV-VST

    Chongqing Precision Biotech Co., Ltd

    Cytomegalovirus Viremia

    mab active

    1 trial

  18. Cardiopulmonary Exercise Testing

    Esperion Therapeutics

    Intrauterine Growth Restriction

    other active

    1 trial

  19. Dynamometric tension assessment

    The First People's Hospital of Lianyungang

    Incisional Hernia

    other completed

    1 trial

  20. FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Neoplasms

    small molecule active

    1 trial

  21. Gemcitabine, cisplatin

    The First People's Hospital of Lianyungang

    Bladder Cancer

    small molecule active

    1 trial

  22. Melatonin supplement intervention

    United Therapeutics Europe Ltd

    Physical Exercise

    small molecule completed

    1 trial

  23. Phase 1 Wonderlab Product

    Chongqing Precision Biotech Co., Ltd

    Diabetes

    other completed

    1 trial

  24. QiMeiYan Probiotics

    Chongqing Precision Biotech Co., Ltd

    IBS - Irritable Bowel Syndrome

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources